Senior Product Designer, Aignostics
AI-powered precision diagnostics for pathology
Posted today
AI-powered precision diagnostics for pathology
101-200 employees
Posted today
101-200 employees
Company mission
To power the next generation of precision medicine and advance the fields of AI and pathology.
Role
Who you are
- A strong portfolio of complex, expert-facing products: You've designed for highly skilled users — enterprise software, developer tools, scientific or clinical workflows. You know how to bring clarity to demanding, information-dense products. Experience in life sciences or biopharma is a meaningful plus
- AI-native in how you work: You're already using AI tools as a core part of your design practice — to prototype quickly, scale your output, and focus your energy where human judgment matters most
- Design system experience: You've built a design system, and know what it takes to create consistency across a product suite from scratch
- Full-stack design range: You’re an expert on UI and interaction design, with the range to design visual identity and brand
What the job involves
- We are hiring a Senior Product Designer to own design across all of Aignostics — from our AI-powered clinical and biopharma products to our marketing presence and brand.
- This is a design full-stack role: you will be the only designer, building our design language from scratch and setting the bar for how our products look, feel, and communicate.
- You'll work closely with engineering, product, and marketing, with a high degree of autonomy and direct impact on the company’s goals
- Build our design language: Create a cohesive design system from the ground up — one that works across our product suite, feels intuitive for expert users, and communicates the quality and ambition of what we're building
- Own product design end-to-end: Drive design across our AI product lines — from early concepts and rapid prototypes through to polished, shipped experiences — working closely with engineering and product
- Shape our brand and marketing presence: Extend the design language beyond the product into marketing materials, and brand guidelines that reflect who Aignostics is
Our take
There has been a worldwide increase in the numbers and complexity of cancer cases, alongside a predicted global shortage of pathologists. With this, classic manual analysis does not have the capability to support the precision medicine and drug development processes of the future.
Through its precision diagnostics platform, Aignostics turns complex biomedical data into transformative insights. It is able to power target identification (for drug development) and biomarker analyses, as well as support clinical trials with its toolkits.
The company is expanding its platform and reach, with initiatives like its Research Access Program driving adoption within the academic community. By offering free access to its spatial analysis tools, Aignostics is strengthening its data assets, validation base, and relationships with key opinion leaders. Alongside its US expansion and collaboration with the Mayo Clinic, these efforts support its long-term growth across research and biopharma applications.
Steph
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 4 rounds)
Oct 2024
$34m
SERIES B
Sep 2022
$16.5m
SERIES A
Total funding: $57.2m
Company HQ
Moabit, Berlin, Germany
Leadership
Viktor Matyas
(Co-Founder & CEO)Prior to co-founding Aignostics in 2019, Viktor was a Senior Associate at Bridgepoint for 3 years.
Maximilian Alber
(Co-Founder & CTO)Maximilian was previously a Researcher at the Berlin Institute of Technology for 4 years.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 3 more jobs at Aignostics